|
|
|
|
 |
SAN DIEGO--- Akesis Pharmaceuticals Names Carl LeBel as President and Chief Operating Officer |
| Companies mentioned in this article: |
|
Amgen, Inc. - Arthur D. Little, Inc. |
|
| 6/30/2008 @ 6:28 AM
print this article -
email to a friend -
join our eNewsletter
|
 |
Akesis Pharmaceuticals, Inc. (OTCBB:AKES), an emerging diabetes drug-development company, today announced it has named Carl LeBel, Ph.D., as president and chief operating officer. Dr. LeBel has served on Akesis’ board of directors since December 2007. The company stated that current president, Jay Lichter, Ph.D., will retain the position of chief executive officer and add the title of chairman of the board of directors.
“The current level of Company activity around our AKP-020 program for the treatment of Type 2 diabetes requires additional management resources, and we are very pleased that Carl LeBel will now be directly involved in the day-to-day progress of our research studies and trials, along with other business development initiatives,” said Lichter.
Dr. LeBel has more than 18 years of experience as a biopharmaceutical industry executive, including 14 years at Amgen Inc. where he was an executive director for program management and strategic operations. Most recently his responsibilities at Amgen included overseeing global cross-functional program activities for a late-stage development candidate in osteoporosis. He has an extensive background in the area of metabolic diseases, including direct experience in the conduct of clinical trials in diabetes and obesity. Prior to joining Amgen, Dr. LeBel held preclinical development positions at Arthur D. Little Inc. and Alkermes Inc. from 1990 to 1993. He holds a B.S. in Chemistry from the University of Detroit, a Ph.D. in Biomedical Sciences/Toxicology from Northeastern University, and was a National Institute of Environmental Health Sciences postdoctoral fellow in Community and Environmental Medicine at the University of California, Irvine. He is also a director at Ash Stevens Inc., a privately held pharmaceutical contract manufacturer.
About Akesis Pharmaceuticals
Akesis Pharmaceuticals has a pipeline of innovative oral product candidates for the treatment of diabetes and related metabolic disorders. These product candidates are supported by issued and filed U.S. patents for both prescription and over-the-counter treatments that combine anti-diabetic trace minerals with certain classes of diabetes oral agents. Akesis' product candidates have demonstrated preliminary evidence of efficacy in lowering and controlling blood glucose levels in patients with Type 2 diabetes. Blood sugar control via oral drugs represents a market opportunity in the billions of dollars, as reports indicate that approximately 20 million people suffer from diabetes in the United States alone. More information can be found at www.akesis.com. |
| Tech People On the Move - California |
|
|
| |
| Monday, October 6, 2008 |
 |
|
SAN DIEGO--- Bio-Quant Adds Dr. Roberto Crea to the Board Posted 6:51 AM PST
SAN DIEGO--- Biocept, Inc. Announces CEO and Director Appointments Posted 6:42 AM PST
|
| |
| Friday, October 3, 2008 |
|
|
IRVINE--- Marc Loupe Appointed CFO of Sage Software, Greg Hammermaster Appointed President of Payment Solutions Division Posted 6:26 AM PST
MURRIETA--- CLX Medical, Inc. Announces Appointment of CEO Vera Leonard to Board of Directors Posted 6:24 AM PST
|
| |
| Thursday, October 2, 2008 |
|
|
BELMONT--- Jameco Electronics Names Greg Harris Vice President of Marketing Posted 2:05 PM PST
FREMONT--- Virage Logic Announces Promotion of Dr. Alex Shubat to CEO, Chairman and Former CEO Dan McCranie Becomes Executive Chairman Posted 11:03 AM PST
SUNNYVALE--- Moonblink Communications Appoints VP of Business Development Posted 5:03 AM PST
|
| |
| Wednesday, October 1, 2008 |
|
|
SAN DIEGO--- GE Capital Solutions, Global Electronics Services Names Dan Hamling Director, IC Test and Assembly Posted 4:00 PM PST
SAN JOSE--- Symmetricom Announces Justin Spencer as New Chief Financial Officer Posted 3:58 PM PST
EL SEGUNDO--- Jay Schwartzberg Joins Accordent to Lead Eastern Region Sales Posted 3:50 PM PST
SAN FRANCISCO--- Stevana Case Joins fatfoogoo Executive Team Posted 9:53 AM PST
SANTA CLARA--- LiveOps Appoints PayPal Executive Ryan D. Downs to Board of Directors Posted 9:52 AM PST
SAN FRANCISCO--- ON24 Names Denise Persson as Chief Marketing Officer to Take Global Virtual Events Leadership to Next Level Posted 9:51 AM PST
MURRIETA--- CLX Medical, Inc. Announces Agreement for Kurt Kalm to Serve as Interim CFO Posted 7:37 AM PST
LOS ALTOS--- TravelMuse Appoints Russ Lemelin as Chief Financial Officer Posted 7:25 AM PST
LOS ANGELES--- iDcentrix Appoints New Technical Director Posted 7:04 AM PST
|
| |
| Monday, September 29, 2008 |
|
|
SAN JOSE--- Tessera Names Michael Anthofer as Executive Vice President and CFO New CFO Brings More Than 30 Years of Technology Company Financial Expertise Posted 8:32 AM PST
SAN FRANCISCO--- Linden Lab Appoints Tom Hale as Chief Product Officer Former Adobe Systems and Macromedia Executive to Join Senior Leadership Team of Linden Lab Posted 8:30 AM PST
|
| |
| Thursday, September 25, 2008 |
|
|
REDWOOD CITY--- PDL BioPharma Names Faheem Hasnain President and Chief Executive Officer Posted 3:54 PM PST
SAN DIEGO--- Anthony Arnerich Appointed Executive Chairman at Accumetrics Posted 3:36 PM PST
SAN DIEGO--- Orexigen Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders Posted 9:14 AM PST
|
| |
| Wednesday, September 24, 2008 |
|
|
SAN FRANCISCO--- Veteran Business Intelligence Professional Dyke Hensen Joins PivotLink as Chief Marketing Officer Posted 6:43 AM PST
SAN DIEGO--- Lpath Appoints John Bender, Pharm.D., as Senior Vice President of Research and Development Posted 6:42 AM PST
|
| |
| Tuesday, September 23, 2008 |
|
|
SAN JOSE--- IDT Names Richard D. Crowley, Jr. As Chief Financial Officer Posted 4:49 PM PST
MOUNTAIN VIEW--- Bytemobile Appoints Telecom Industry Veteran Nick Henry as Vice President, Worldwide Systems Integration Posted 8:53 AM PST
SAN DIEGO--- Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development Posted 8:48 AM PST
MOUNTAIN VIEW--- Technology Industry Veteran Fred Hessabi Joins BDNA Board of Directors Posted 8:42 AM PST
LOS ANGELES--- ImmunoCellular Therapeutics Elects Dr. James Bender to Position of Vice President, Clinical Development Posted 8:34 AM PST
SAN DIEGO--- Joshua Haims Joins Networkcar as Vice President of Finance Posted 7:57 AM PST
|
|
|
|
|
|
FreshNews.com Jobs Change DAILY
We Have 5,000 + Job Listings! Open Your FREE Account
Employers or Job Searchers Get Started Now! Click Here
|
